UB Paderborn / Katalog / Suche / in CDI

Case-Control Evaluation of the Effectiveness of the G1P[8] Human Rotavirus Vaccine during an Outbreak of Rotavirus G2P[4] Infection in Central Australia

Clinical infectious diseases, 2011-01, Vol.52 (2), p.191-199

2011

Volltextzugriff (PDF)

The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high‐income setting: a prospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2020-01, Vol.127 (1), p.47-56

2020

Volltextzugriff (PDF)

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial

Vaccine, 2010-04, Vol.28 (19), p.3341-3349

2010

Volltextzugriff (PDF)

Echocardiographic screening in a resource poor setting: Borderline rheumatic heart disease could be a normal variant

International journal of cardiology, 2014-05, Vol.173 (2), p.284-289

2014

Volltextzugriff (PDF)

Environmental and social determinants of acute rheumatic fever: a longitudinal cohort study

Epidemiology and infection, 2019-01, Vol.147, p.e79-e79, Article e79

2019

Volltextzugriff (PDF)

Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections

Clinical infectious diseases, 2014-08, Vol.59 (3), p.358-365

2014

Volltextzugriff (PDF)

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

Vaccine, 2009-09, Vol.27 (41), p.5685-5691

2009

Volltextzugriff (PDF)

The fall and rise of Group A Streptococcus diseases

Epidemiology and infection, 2019-01, Vol.147, p.1, Article e4

2019

Volltextzugriff (PDF)

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age

Vaccine, 2011-01, Vol.29 (3), p.535-544

2011

Volltextzugriff (PDF)

Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster

Clinical and Vaccine Immunology, 2010-12, Vol.17 (12), p.1970-1976

2010

Volltextzugriff (PDF)

As a Bacterial Culture Medium, Citrated Sheep Blood Agar Is a Practical Alternative to Citrated Human Blood Agar in Laboratories of Developing Countries

Journal of Clinical Microbiology, 2006-09, Vol.44 (9), p.3346-3351

2006

Volltextzugriff (PDF)

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

Vaccine, 2010-04, Vol.28 (18), p.3086-3094

2010

Volltextzugriff (PDF)

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

Vaccine, 2011-06, Vol.29 (27), p.4499-4506

2011

Volltextzugriff (PDF)

Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever

Archives of disease in childhood, 2001-09, Vol.85 (3), p.223-227

2001

Volltextzugriff (PDF)

Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors

Journal of paediatrics and child health, 2002-06, Vol.38 (3), p.229-234

2002

Volltextzugriff (PDF)

Preliminary validation of a novel high-resolution melt-based typing method based on the multilocus sequence typing scheme of Streptococcus pyogenes

Clinical microbiology and infection, 2011-09, Vol.17 (9), p.1426-1434

2011

Volltextzugriff (PDF)

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

Clinical microbiology and infection, 2013-05, Vol.19 (5), p.E222-E229

2013

Volltextzugriff (PDF)

Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection

Epidemiology and infection, 2007-11, Vol.135 (8), p.1398-1405

2007

Volltextzugriff (PDF)

High burden of invasive β-haemolytic streptococcal infections in Fiji

Epidemiology and infection, 2008-05, Vol.136 (5), p.621-627

2008

Volltextzugriff (PDF)

The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease

Epidemiology and infection, 2008-04, Vol.136 (4), p.529-539

2008

Volltextzugriff (PDF)

Low Rates of Streptococcal Pharyngitis and High Rates of Pyoderma in Australian Aboriginal Communities Where Acute Rheumatic Fever Is Hyperendemic

Clinical infectious diseases, 2006-09, Vol.43 (6), p.683-689

2006

Volltextzugriff (PDF)

Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?

Epidemiology and infection, 2000-04, Vol.124 (2), p.239-244

2000

Volltextzugriff (PDF)

Chest X-ray-confirmed pneumonia in children in Fiji

Bulletin of the World Health Organization, 2005-06, Vol.83 (6), p.427-433

2005

Volltextzugriff (PDF)

Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting

Clinical microbiology and infection, 2018-09, Vol.24 (9), p.1027-1029

2018

Volltextzugriff (PDF)

Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory

Tropical medicine & international health, 2015-01, Vol.20 (1), p.40-47

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Case-Control Evaluation of the Effectiveness of the G1P[8] Human Rotavirus Vaccine during an Outbreak of Rotavirus G2P[4] Infection in Central Australia

The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high‐income setting: a prospective cohort study

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial

Echocardiographic screening in a resource poor setting: Borderline rheumatic heart disease could be a normal variant

Environmental and social determinants of acute rheumatic fever: a longitudinal cohort study

Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

The fall and rise of Group A Streptococcus diseases

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age

Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster

As a Bacterial Culture Medium, Citrated Sheep Blood Agar Is a Practical Alternative to Citrated Human Blood Agar in Laboratories of Developing Countries

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever

Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors

Preliminary validation of a novel high-resolution melt-based typing method based on the multilocus sequence typing scheme of Streptococcus pyogenes

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection

High burden of invasive β-haemolytic streptococcal infections in Fiji

The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease

Low Rates of Streptococcal Pharyngitis and High Rates of Pyoderma in Australian Aboriginal Communities Where Acute Rheumatic Fever Is Hyperendemic

Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?

Chest X-ray-confirmed pneumonia in children in Fiji

Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting

Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory

Suchergebnisse filtern